Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Magnan

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Pediatric Hematology/Oncology|January 7, 2017
Intracardiac Low-grade Sarcoma Following Treatment for Ewing SarcomaMichael V Ortiz, Heather Magnan, Emily K Slotkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Disease Models & Mechanisms|November 29, 2021
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signalingRoger S Smith, Igor Odintsov, Zebing Liu, et al.
Cell Reports|November 24, 2021
Immuno-transcriptomic profiling of extracranial pediatric solid malignanciesAndrew S Brohl, Sivasish Sindiri, Jun S Wei, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Pediatric Hematology/Oncology|January 7, 2017
Intracardiac Low-grade Sarcoma Following Treatment for Ewing SarcomaMichael V Ortiz, Heather Magnan, Emily K Slotkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Disease Models & Mechanisms|November 29, 2021
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signalingRoger S Smith, Igor Odintsov, Zebing Liu, et al.
Cell Reports|November 24, 2021
Immuno-transcriptomic profiling of extracranial pediatric solid malignanciesAndrew S Brohl, Sivasish Sindiri, Jun S Wei, et al.
Pageof 3